This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: University of Tsukuba, The University of Texas System. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 197 
2 out of 5,645 
Years Active: 2019-2023
Title: Tsuyoshi Saitoh: Innovator in Orexin Receptor Research
Introduction
Tsuyoshi Saitoh is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target orexin receptors. With a total of 3 patents, his work is paving the way for new therapeutic options for various sleep disorders and drug dependence.
Latest Patents
One of Saitoh's latest patents is focused on a sulfonamide derivative or pharmaceutically acceptable acid-addition salt. This invention aims to provide a novel low-molecular-weight compound that exhibits orexin receptor agonist activity. It is expected to be useful as a prophylactic or therapeutic agent for narcolepsy and similar conditions. The compound is represented by a specific formula, which is detailed in the patent description.
Another significant patent involves a morphinan derivative and its medical usage. The purpose of this invention is to offer a compound that serves as a prophylactic or therapeutic agent for various diseases related to orexin receptors. The morphinan derivative demonstrates excellent selectivity and antagonism against orexin receptors, providing therapeutic effects on drug dependence.
Career Highlights
Tsuyoshi Saitoh has worked at esteemed institutions such as the University of Tsukuba and the University of Texas System. His research has been instrumental in advancing the understanding of orexin receptors and their implications in medical science.
Collaborations
Throughout his career, Saitoh has collaborated with notable colleagues, including Hiroshi Nagase and Masashi Yanagisawa. These partnerships have contributed to the depth and breadth of his research in the field.
Conclusion
Tsuyoshi Saitoh's innovative work in the realm of orexin receptor research is making a significant impact on the development of new therapeutic agents. His patents reflect a commitment to addressing critical health issues, particularly in the areas of sleep disorders and drug dependence.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile